The gut microbiota during tamoxifen therapy in patients with breast cancer

The gut microbiota during tamoxifen therapy in patients with breast cancer

Abstract Tamoxifen is essential in treating estrogen receptor-positive (ER+) breast cancer, primarily through its active metabolite, endoxifen. Emerging research suggests potential interactions between tamoxifen and gut microbiota. This study investigates the effects of tamoxifen on gut microbiota c...

ver descrição completa

Detalhes bibliográficos
Principais autores: Lars E. Hillege, David J. M. Barnett, Janine Ziemons, Romy Aarnoutse, Judith de Vos-Geelen, Robin van Geel, Maaike de Boer, Yvonne E. A. van Riet, Jeroen Vincent, John Penders, Marjolein L. Smidt
Formato: Artigo
Idioma:English
Publicado em: Nature Portfolio 2025-03-01
coleção:Scientific Reports
Assuntos:
Breast neoplasms
Antineoplastic agents
Postmenopausal
Acesso em linha:https://doi.org/10.1038/s41598-025-91734-1

Internet

https://doi.org/10.1038/s41598-025-91734-1

Registros relacionados